Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-046524
Filing Date
2013-08-27
Accepted
2013-08-27 09:36:34
Documents
1
Period of Report
2013-08-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rrd389180.html 4  
1 PRIMARY DOCUMENT rrd389180.xml 4 2918
  Complete submission text file 0001181431-13-046524.txt   4347
Mailing Address C/O RXI PHARMACEUTICALS CORPORATION 1500 WEST PARK DRIVE, SUITE 210 WESTBOROUGH MA 01581
Business Address
Bitterman Robert J (Reporting) CIK: 0001304395 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54910 | Film No.: 131061644

Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations